Systemic Inflammatory Markers and Clinical Outcomes of Open versus Biportal Endoscopic Transforaminal Lumbar Interbody Fusion
Therapeutics and Clinical Risk Management · 2024-05 · Volume 20 · 249-259
DOI: 10.2147/tcrm.s447394 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutics and Clinical Risk Management, 2024-05. Verfasst von Liwen Feng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Weihaiwei People's Hospital, Weihai, Shandong Province, 264200, People's Republic of China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Purpose
The purpose of this study is to preliminarily assess the change in perioperative systemic inflammatory markers and clinical outcomes between open TLIF and BE-TLIF procedures. Patients and Methods: In total, 38 patients who underwent single-level lumbar fusion surgery (L4-5 or L5-S1) were retrospectively reviewed. 19 patients were treated by the BE-TLIF technique, while the other patients were managed using open TLIF. The perioperative serum C-reactive protein (CRP), neutrophil/lymphocyte ratio (NLR), lymphocyte/monocyte ratio (LMR), and platelet/lymphocyte ratio (PLR) of the two groups were compared to determine if there was a statistical difference. Meanwhile, clinical evaluations were conducted to assess various factors including operative duration, estimated blood loss (EBL), drainage catheter stay, length of hospitalization, visual analogue scale (VAS), and Oswestry disability index (ODI) scores.
Results
The perioperative analysis revealed that BE-TLIF cases experienced a longer operative duration than open TLIF cases (open TLIF: 138.63 ± 31.59 min, BE-TLIF: 204.58 ± 49.37 min, p 0.05). The VAS and ODI scores in both groups were significantly improved after surgery (p < 0.05).
Conclusion
There was no significant difference found between BE-TLIF and open TLIF in terms of systemic inflammatory markers, and clinical outcomes. Overall, BE-TLIF can be considered a viable choice for lumbar canal decompression and interbody fusion for less invasion. It is worth noting that BE-TLIF does have a longer operation time, indicating that there is still potential for further improvement in this technique.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedics, Weihaiwei People's Hospital, Weihai, Shandong Province, 264200, People's Republic of China.
- Department of Orthopedics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, 250021, People's Republic of China.
ORCID-Profile: Qingyu Zhang
Zitieren
APA
Feng, L., Liang, J., Wang, N., & Zhang, Q. (2024). Systemic Inflammatory Markers and Clinical Outcomes of Open versus Biportal Endoscopic Transforaminal Lumbar Interbody Fusion. Therapeutics and Clinical Risk Management, Volume 20, 249-259. https://doi.org/10.2147/tcrm.s447394
Vancouver
Feng L, Liang J, Wang N, Zhang Q. Systemic Inflammatory Markers and Clinical Outcomes of Open versus Biportal Endoscopic Transforaminal Lumbar Interbody Fusion. Therapeutics and Clinical Risk Management. 2024;Volume 20:249-259. doi:10.2147/tcrm.s447394
BibTeX
@article{Feng2024,
author = {Feng, Liwen and Liang, Junbo and Wang, Naiguo and Zhang, Qingyu},
title = {Systemic Inflammatory Markers and Clinical Outcomes of Open versus Biportal Endoscopic Transforaminal Lumbar Interbody Fusion},
journal = {Therapeutics and Clinical Risk Management},
year = {2024},
volume = {Volume 20},
pages = {249--259},
doi = {10.2147/tcrm.s447394}
}
EUVIMED